Palomino Laboratories Inc. cash flow statement PALX

In fiscal 2025, which ended Dec 31, 2025, Palomino Laboratories Inc. used $1.3 million of cash from operations, down 26285.0% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
Operating
Stock-based compensation
—
1
—
—
Operating cash flow
-3
-6135.1%
-1
-26285.0%
-0
+93.9%
-0
Financing
Financing cash flow
22
+1122.1%
9
+4644.1%
0
+146.6%
0
Change in cash
Net change in cash
—
8
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Semiconductors & Related Devices (SIC 3674)
Listed as
PALX (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Goleta, CA
SEC filer status
, Emerging growth company
SEC CIK
1938569
Former names
Unite Acquisition 3 Corp. (until Aug 29, 2025)

Other Semiconductors & Related Devices companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.